Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1634 1682
This examiner grants 20% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17511353 | DETECTING MATERIALS IN A MIXTURE USING OLIGONUCLEOTIDES | Final Rejection | ILLUMINA, INC. |
| 17439063 | CRISPR EFFECTOR SYSTEM BASED MULTIPLEX DIAGNOSTICS | Final Rejection | PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
| 17419641 | DNA METHYLATION BASED ESTIMATOR OF TELOMERE LENGTH | Non-Final OA | The Regents of the University of California |
| 17416510 | Optimizing Detection of Transplant Injury by Donor-Derived Cell-Free DNA | Final Rejection | The Regents of the University of California |
| 17352162 | SENSITIVE AND MULTIPLEXED DETECTION OF NUCLEIC ACIDS AND PROTEINS FOR LARGE SCALE SEROLOGICAL TESTING | Non-Final OA | California Institute of Technology |
| 19236732 | METHODS, COMPOSITONS AND SYSTEMS FOR ANALYTE DETECTION | Final Rejection | Stellaromics, Inc. |
| 18193886 | EPOXIDES FOR MULTIMODAL DETECTION OF BIOMOLECULES | Non-Final OA | Massachusetts Institute of Technology |
| 19087021 | METHODS, KITS, AND COMPOSITIONS FOR SPATIAL DETECTION OF GENETIC VARIANTS | Final Rejection | 10x Genomics, Inc. |
| 19019374 | METHOD OF DETECTING TARGET NUCLEIC ACID MOLECULES | Final Rejection | 10x Genomics, Inc. |
| 18344339 | METHODS FOR DETERMINING A LOCATION OF A TARGET NUCLEIC ACID IN A BIOLOGICAL SAMPLE | Final Rejection | 10x Genomics, Inc. |
| 18313251 | ANALYSIS OF ANTIGEN AND ANTIGEN RECEPTOR INTERACTIONS | Non-Final OA | 10x Genomics, Inc. |
| 18165226 | METHODS FOR DETERMINING A LOCATION OF A TARGET NUCLEIC ACID IN A BIOLOGICAL SAMPLE | Final Rejection | 10x Genomics, Inc. |
| 17877664 | COMPOSITIONS AND METHODS FOR ANALYSIS USING NUCLEIC ACID PROBES AND BLOCKING SEQUENCES | Final Rejection | 10x Genomics, Inc. |
| 17165808 | PROBES AND METHODS OF USING SAME | Final Rejection | 10x Genomics, Inc. |
| 17780833 | NUCLEIC ACID SEQUENCE MEASURING APPARATUS, NUCLEIC ACID SEQUENCE MEASURING METHOD, AND NON-TRANSITORY RECORDING MEDIUM | Final Rejection | Yokogawa Electric Corporation |
| 14904170 | DETECTION OF TARGET NUCLEIC ACID SEQUENCE BY PTO CLEAVAGE AND EXTENSION-DEPENDENT IMMOBILIZED OLIGONUCLEOTIDE HYBRIDIZATION | Non-Final OA | SEEGENE, INC. |
| 17171629 | ANTIMICROBIAL SUSCEPTIBILITY TESTING USING MICRODROPLETS | Final Rejection | Becton, Dickinson and Company |
| 17151058 | METHODS AND COMPOSITIONS FOR SINGLE CELL SECRETOMICS | Final Rejection | Becton, Dickinson and Company |
| 17428475 | METHODS FOR CANCER SCREENING AND MONITORING BY CANCER MASTER REGULATORS MARKERS IN LIQUID BIOPSY | Final Rejection | University of Florida Research Foundation, Incorporated |
| 18020915 | AMINO-MODIFIED CHIP, PREPARATION METHOD THEREFOR AND USE THEREOF | Final Rejection | GeneMind Biosciences Co., Ltd. |
| 18873220 | NUCLEIC ACID AND GENE SYNTHESIS | Final Rejection | NunaBio Limited |
| 18915941 | PROXIMITY DETECTION OF BIOMOLECULE INTERACTIONS | Final Rejection | Singular Genomics Systems, Inc. |
| 18309128 | MANIPULATING AND DETECTING BIOLOGICAL SAMPLES | Final Rejection | Singular Genomics Systems, Inc. |
| 18157170 | SEQUENCING COMPLEMENTARY POLYNUCLEOTIDES | Final Rejection | Singular Genomics Systems, Inc. |
| 18050688 | METHODS AND COMPOSITIONS USEFUL FOR NUCLEIC ACID SEQUENCING | Final Rejection | Singular Genomics Systems, Inc. |
| 16646598 | SINGLE-MOLECULE PHENOTYPING AND SEQUENCING OF NUCLEIC ACID MOLECULES | Non-Final OA | Oxford University Innovation Limited |
| 18530606 | METHODS AND SYSTEMS FOR REDUCING PHASING ERRORS WHEN SEQUENCING NUCLEICACIDS USING TERMINATION CHEMISTRY | Final Rejection | LIFE TECHNOLOGIES CORPORATION |
| 17932816 | NUCLEIC ACID DETECTION CHIP AND THE METHOD AND DETECTION EQUIPMENT USING THE SAME | Non-Final OA | NATIONAL APPLIED RESEARCH LABORATORIES |
| 18019375 | NUCLEIC ACID STRUCTURE | Final Rejection | THE SCHOOL CORPORATION KANSAI UNIVERSITY |
| 16279203 | DETECTION OF MICROSATELLITE INSTABILITY | Final Rejection | Roche Molecular Systems, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy